180624-08-2

Basic information

• Product Name: 4-bromo-2-iodo-6-nitroaniline
• Synonyms: 4-bromo-2-iodo-6-nitroaniline;4-BroMo-2-iodo-6-nitro-phenylaMine
• CAS NO: 180624-08-2
• Molecular Formula: C₆H₄BrIN₂O₂
• Molecular Weight: 342.91663
• Mol File: 180624-08-2.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 4-bromo-2-iodo-6-nitroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-iodo-6-nitroaniline(180624-08-2)
• EPA Substance Registry System: 4-bromo-2-iodo-6-nitroaniline(180624-08-2)

Safety Data

• Hazardous Substances Data: 180624-08-2(Hazardous Substances Data)

Usage

Uses

4-Bromo-2-iodo-6-nitroaniline is a useful research chemical compound.

Upstream product

• 875-51-4 4-Bromo-2-nitroaniline 
• 473-34-7 N,N-dichloro-p-toluenesulfonamide 
• 64-19-7 acetic acid 
• 88-74-4 2-nitro-aniline 

Downstream Products

• 1000289-32-6 1-benzoyl-3-(3-bromo-5-iodophenyl)thiourea 
• 1000289-33-7 (3-bromo-5-iodophenyl)thiourea 

Relevant articles and documents

Total synthesis of kealiiquinone: the regio-controlled strategy for accessing its 1-methyl-4-arylbenzimidazolone core

A practical, concise and straightforward total synthesis of kealiiquinone 1, a naphtho[2,3-d]imidazole alkaloid obtained from the Micronesian marine sponge Leucetta sp. was accomplished. The squaric acid chemistry to construct the 1,4-quinoid ring and the regioselective N-methylation through a benzo[c][1,2,5]selenadiazolium heterocycle are the key features in this report. The full details of the representative approaches involving the different attempted synthetic strategies are also presented. Finally a successful total synthesis of this complex secondary metabolite is described.

Anti-osteoporosis compound as well as derivatives, pharmaceutical composition, preparation method and application thereof

The invention discloses an anti-osteoporosis compound as well as derivatives, a pharmaceutical composition, a preparation method and application thereof. The structure of the compound is shown in a formula (I), the derivatives of the compound relate to an

Preparation method of 3-acetylindole BRPF1 inhibitor and use of 3-acetylindole BRPF1 inhibitor

The invention relates to a 3-acetylindole compound of a novel structure shown in a formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate or a solvate thereof, a preparation method of the compound, a pharmaceutical composition containing a therapeutically effective dose of the compound, and use thereof as a protein tyrosine kinase inhibitor, especially as a bromine-containing area PHD zinc finger protein 1 (BRPF1) inhibitor, in the prevention or treatment of disease benefited from the inhibition of BRPF1.